News - Rest of the World, Neurological


Popular Filters

Eisai expands in South Africa, filing for approval of Halaven and Fycompa


Japanese drug major Eisai (TYO: 4523) says it is expanding its operations into South Africa, with the…

EisaiFycompaHalavenMarkets & MarketingNeurologicalOncologyPharmaceuticalRegulationRest of the World

Eisai launches Lunesta in Japan, debuts Zebinix in France; opens Dubai office


Japanese drug major Eisai (TYO: 4523) says it launched the insomnia treatment Lunesta (eszopiclone) in…

Asia-PacificEisaiEuropeLunestaMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldZebinix

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top